Background
Obesity, obese, CKD, chronic kidney disease, diabetes mellitus, chronic diseases, overweight, weight loss
OBESITY, OBESE, DIABETES MELLITUS, CHRONIC DISEASES, HYPERTENSION
Edited by: Claudia Vetrani, Pegaso University, ItalyReviewed by: Xiaoyong Yu, Shaanxi Provincial Hospital of Traditional Chinese Medicine, China; Girish C. Melkani, University of Alabama at Birmingham, United States; Baoli Liu, Capital Medical University, China; Yi Wang, Shanghai University of Traditional Chinese Medicine, China; Xuezhong Gong, Shanghai Municipal Hospital of Traditional Chinese Medicine, ChinaThis article was submitted to Obesity, a section of the journal Frontiers in EndocrinologyTime-restricted feeding (TRF) has become a popular weight loss method in recent years. It is widely used in the nutritional treatment of normal obese people and obese people with chronic diseases such as diabetes mellitus and hypertension, and has shown many benefits. However, most TRF studies have excluded chronic kidney disease (CKD) patients, resulting in a lack of sufficient evidence-based practice for the efficacy and safety of TRF therapy for CKD. Therefore, we explore the efficacy and safety of TRF in overweight and obese patients with moderate-to-severe stage CKD through this pilot study, and observe patient compliance to assess the feasibility of the therapy.